Lode H - Search Results

1

Defining, treating and preventing hospital acquired pneumonia: European perspective.

Torres A, Ewig S, Lode H, Carlet J; European HAP working group. Torres A, et al. Among authors: lode h. Intensive Care Med. 2009 Jan;35(1):9-29. doi: 10.1007/s00134-008-1336-9. Epub 2008 Nov 7. Intensive Care Med. 2009. PMID: 18989656

2

Hospital-acquired pneumonia in Europe.

Torres A, Ewig S, Lode H, Carlet J. Torres A, et al. Among authors: lode h. Eur Respir J. 2009 May;33(5):951-2. doi: 10.1183/09031936.00004509. Eur Respir J. 2009. PMID: 19407045 Free article. No abstract available.

3

[What are the reasons for our choice? Proofs, recommendations or habit?].

Lode H, Torres A, Cockle A. Lode H, et al. Med Mal Infect. 2007 Nov;37 Spec No 1:17-22. Med Mal Infect. 2007. PMID: 18376505 French. No abstract available.

4

Bacterial community-acquired pneumonia: risk factors for mortality and supportive therapies.

Lode H. Lode H. Intensive Care Med. 2009 Mar;35(3):391-3. doi: 10.1007/s00134-008-1366-3. Epub 2008 Dec 10. Intensive Care Med. 2009. PMID: 19066849 No abstract available.

5

Initial therapy in pneumonia. Clinical, radiographic, and laboratory data important for the choice.

Löde H. Löde H. Am J Med. 1986 May 30;80(5C):70-4. Am J Med. 1986. PMID: 3717191

6

Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.

Cantón R, Lode H, Graninger W, Milkovich G. Cantón R, et al. Among authors: lode h. Int J Antimicrob Agents. 2006 Sep;28 Suppl 2:S115-27. doi: 10.1016/j.ijantimicag.2006.06.001. Epub 2006 Aug 14. Int J Antimicrob Agents. 2006. PMID: 16904873 Review.

7

[S2 guideline for infectious endocarditis].

Naber CK, Bauhofer A, Block M, Buerke M, Erbel R, Graninger W, Herrmann M, Horstkotte D, Kern P, Lode H, Mehlhorn U, Meyer J, Mügge A, Niebel J, Peters G, Shah PM, Werdan K. Naber CK, et al. Among authors: lode h. MMW Fortschr Med. 2004 Dec 9;146(Suppl 3-4):123-35. MMW Fortschr Med. 2004. PMID: 15662902 Review. German.

8

[Endocarditis as an interdisciplinary problem].

Lode H. Lode H. Fortschr Med. 1984 Jul 12;102(25-26):21. Fortschr Med. 1984. PMID: 6469186 German. No abstract available.

9

[Progress with management of hereditary angioedema].

Johnston DT, Lode H. Johnston DT, et al. Among authors: lode h. MMW Fortschr Med. 2013 Mar 21;155 Suppl 1:1-5. doi: 10.1007/s15006-013-0730-6. MMW Fortschr Med. 2013. PMID: 23678665 Review. German.

10

Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers.

Fischer-Riepe L, Kailayangiri S, Zimmermann K, Pfeifer R, Aigner M, Altvater B, Kretschmann S, Völkl S, Hartley J, Dreger C, Petry K, Bosio A, von Döllen A, Hartmann W, Lode H, Görlich D, Mackensen A, Jungblut M, Schambach A, Abken H, Rossig C. Fischer-Riepe L, et al. Among authors: lode h. Clin Cancer Res. 2024 Apr 9:OF1-OF14. doi: 10.1158/1078-0432.CCR-23-3157. Online ahead of print. Clin Cancer Res. 2024. PMID: 38593230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

621 results

Search Page